A22.1
Pulmonary anthrax
Clinical Classification Guidelines
Inclusion Terms
- Inhalation anthrax
- Ragpicker's disease
- Woolsorter's disease
Medical Intelligence & Overview
Pulmonary anthrax, also known as inhalation anthrax or Woolsorter's disease, is a serious infectious disease caused by the bacteria Bacillus anthracis. It primarily affects the lungs and can be life-threatening if not diagnosed and treated promptly. This rare disease can develop after inhaling spores from contaminated materials, making it a concern for certain occupational groups and in the context of biological threats.
Causes & Symptoms
Clinical Causes: Inhalation of spores from contaminated animal products or dust containing Bacillus anthracis bacteria Exposure during handling or processing of infected wool, animal hides, or animal products Accidental laboratory exposure to spores in research settings Bioterrorism involving aerosolized spores
Key Symptoms: Fever and chills Cough, which can be dry or productive Chest discomfort or pain Shortness of breath or difficulty breathing Fatigue and weakness Muscle aches Headache Nausea or vomiting in some cases Swelling or redness in the neck or chest area
Diagnostic & Treatment
Diagnosis Path: Diagnosis is based on a combination of clinical symptoms, history of exposure, and laboratory tests. These may include blood cultures, chest X-rays, and polymerase chain reaction (PCR) testing to identify Bacillus anthracis. Imaging studies can reveal mediastinal widening or infiltrates characteristic of pulmonary anthrax.
Treatment Protocols: Prompt administration of antibiotics such as ciprofloxacin or doxycycline is crucial. Treatment may also involve hospitalization and supportive care to manage respiratory distress or other complications. Early intervention can substantially improve outcomes and reduce mortality risk.
Clinical Advice & FAQs
Billing Guidance
Is A22.1 a billable ICD-10 code?
Yes, A22.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A22.1?
Clinical documentation must specify the nature of Pulmonary anthrax and any associated comorbidities for accurate reporting.
Cite this Clinical Reference